Home
About
FAQ
History (5)
A multicentre international randomized parallel group double-blind placebo-controlled clinical trial of EMPAgliflozin once daily to assess cardio-renal outcomes in patients with chronic KIDNEY disease
Adults with autism spectrum disorders exhibit decreased sensitivity to reward parameters when making effort-based decisions.
Exercise plus caloric restriction lowers soluble RAGE in adults with chronic kidney disease.
Impact of a physician-in-triage process on resident education.
Red blood cell polyunsaturated fatty acids and mortality in the Women's Health Initiative Memory Study.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A multicentre international randomized parallel group double-blind placebo-controlled clinical trial of EMPAgliflozin once daily to assess cardio-renal outcomes in patients with chronic KIDNEY disease
Biography
contributor
Principal Investigator
Time
start date
2019-09-01
end date
2023-08-31
